Why are the majority of hereditary cases of early-onset breast cancer sporadic? A simulation study

Cancer Epidemiology Biomarkers and Prevention

Volumn 9, Issue 8, 2000, Pages 805-812

  Cui, J ^a   Hopper, J L ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ARTICLE; BREAST CANCER; FAMILIAL CANCER; FAMILY HISTORY; GENE FREQUENCY; GENE MUTATION; GERM LINE; PEDIGREE; PRIORITY JOURNAL; PROBABILITY; STATISTICAL ANALYSIS; STATISTICS;

ADULT; AGE DISTRIBUTION; AGE OF ONSET; AGED; AUSTRALIA; BREAST NEOPLASMS; COMPUTER SIMULATION; FAMILY HEALTH; FEMALE; GENE FREQUENCY; GENES, BRCA1; GREAT BRITAIN; HUMANS; JEWS; MIDDLE AGED; MODELS, GENETIC; MUTATION; PEDIGREE; PREVALENCE; SINGAPORE; WASHINGTON;

EID: 0033843018     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Linkage of early-onset familial breast cancer to chromosome 17q21
2. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13
3. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1
4. Identification of the breast-cancer susceptibility gene BRCA2
5. BRCA1 mutations and breast cancer in the general population-analyses in women before age 35 years and in women before age 45 years with first-degree family history
6. The prevalence of BRCA1 mutations in Chinese patients with early onset breast cancer and affected relatives
7. Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2
8. Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer
9. The risk of cancer associated with specific mutation of BRCA1 and BRCA2 among Ashkenazi Jews
10. The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi
11. Modeling the probability that Ashkenazi Jewish women carry a founder mutation in BRCA1 or BRCA2
12. Genetic linkage analysis in familial breast and ovarian cancer: Results from 214 families
13. Genetic heterogeneity of breast-ovarian cancer revisited
14. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families
15. Cancer risks in BRCA2 mutation carriers
16. Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients
17. Semiparametric estimation of major gene and family-specific random effects for age of onset
18. Genetic analysis of breast cancer in the Cancer and Steroid Hormone Study
19. Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: Results from three U.S. population-based case-control studies of ovarian cancer
20. Cancer mortality in relatives of women with ovarian cancer: The OPCS study
21. Cancer mortality in relatives or women with breast cancer: The OPCS study
22. Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence
23. Risk factors and preventive strategies for breast cancer
24. Design and analysis issues in a population-based, case-control-family study of the genetic epidemiology of breast cancer and the Co-operative Family Registry for Breast Cancer Studies (CFRBCS)
25. The importance of a family history of breast cancer in predicting the presence of a BRCA mutation
26. De novo BRCA1 mutation in a patient with breast cancer and an inherited BRCA2 mutation
27. The Australian breast cancer family study: Putting breast cancer genes into perspective